Ad www.AngelOne.in
FREE Account Opening + Zero AMC Fees* + MutualFund SIP1
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Ad www.AngelOne.in
NCD Status: Closed [19th Oct 2023 to 30th Oct 2023]
Piramal Enterprises Limited is issuing secured and redeemable NCDs with a base issue size of Rs 1000.00 Cr and shelf issue size of Rs 3000.00 Cr. The subscription period is from October 19, 2023 to November 02, 2023 and the company is issuing Series I to IV at an issue price of Rs. 1000 per NCD. The NCDs can be subscribed for a minimum amount of Rs. 10,000 (10 NCDs) . The face value of each NCD is Rs. 1000. The tenure of the NCDs is 2, 3, 5 and 10 years with a coupon rate of 9.00 % to 9.35% per annum.
Learn more about Piramal Enterprises Limited including credit rating, coupon rates for each series, basis of allotment, payment frequency and more.
| NCD Opening Date: | 19th Oct 2023 |
| NCD Closing Date: | 30th Oct 2023 |
| NCD Type: | Secured NCD |
| Issue Size (Base): | ₹1000.00Cr |
| Issue Size (Shelf): | ₹3000.00Cr |
| Face Value: | Rs 1000 each NCD |
| Issue Price: | Rs 1000 per NCD |
| Market Lot: | 1 NCD |
| Min Order Qty: | 10 NCD |
| Min Order Amount: | Rs 10000 |
| Listing at: | BSE, NSE |
| Tenor: | 2 , 3, 5 and 10 years |
| Rating: | [ICRA]AA (Stable) by ICRA Limited and CARE AA (Stable) by CARE Ratings Limited |
| Series: | Series I to IV |
| Payment Frequency: | Anually |
| Basis of Allotment: | |
| Interest on return: |
Zerodha Trade@20
| NCD Activity | Date |
|---|---|
| NCD Issue Open | 19th Oct 2023 |
| NCD Issue Close | 30th Oct 2023 |
| BSE Code: | 3185 |
| BSE Script Symbol: | PELNCD1 |
| NSE Code: | PELNCD1 |
* - Tentative Dates
| Category Name | NCD's Reserved | NCD's Allocated |
|---|---|---|
| Institutional | 400000 | 20% |
| Non-Institutional | 400000 | 20% |
| HNI | 600000 | 30% |
| Retail | 600000 | 30% |
Piramal Enterprises Limited was incorporated in April 1947. The company divides its business activities into the following core business segments: Financial Services, Pharmaceuticals and Healthcare Insights & Analytics. The Financial Services and Pharmaceuticals businesses are further divided into various sub-divisions. The Financial Services business currently includes (i) wholesale lending and (ii) alternative asset management.
They have made strategic investments in Shriram Group which gives us access to a retail lending platform. The Pharmaceuticals business is divided into (i) the Global Pharmaceuticals business, which includes fully integrated end-to-end pharmaceutical development and manufacturing services offerings for other pharmaceutical companies and a portfolio of differentiated branded hospital and generic products, and (ii) the Indian Over-the-Counter Pharmaceuticals business.
The company's global pharmaceuticals business is present in over 110 countries with manufacturing facilities in India, the United States, the United Kingdom and Canada, while its Indian OTC consumer products business has an India-wide distribution network. The Healthcare Insights & Analytics business operates in a niche area of data and technology-driven pharmaceutical and healthcare market research to provide customers across the healthcare value chain with insights into their existing and future business opportunities.
| Period Ended | 30 Mar 2023 | 31 Mar 2022 |
| Assets | 74,436.54 | 84,300.28 |
| Revenue | 9,086.74 | 7,910.89 |
| Profit After Tax | 9,968.58 | 1,998.77 |
| Net Worth | 31,059.00 | 30,120.00 |
| Reserves and Surplus | ||
| Total Borrowing | ||
| Amount in ₹ Crore | ||
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
Piramal Enterprises Limited NCD Coupon Rates
| # | Series 1 | Series 2 | Series 3 | Series 4 |
|---|---|---|---|---|
| Frequency of Interest Payment | Annual | Annual | Annual | Annual |
| Nature | Secured | Secured | Secured | Secured |
| Tenor | 2 Years | 3 Years | 5 Years | 10 Years |
| Coupon (% per Annum) | 9.00% | 9.05% | 9.20% | 9.35% |
| Effective Yield (% per Annum) | 9.00% | 9.05% | 9.19% | 9.34% |
| Amount on Maturity (In Rs.) | Rs 1,000.00 | Rs 1,000.00 | Rs 1,000.00 | Rs 1,000.00 |
The company Promoter is Ajay G. Piramal.
The company has received a rating of [ICRA]AA (Stable) by ICRA Limited and CARE AA (Stable) by CARE Ratings Limited for the NCDs proposed to be issued pursuant to this Issue.
Last Updated on 2023-11-02T06:32:52+00:00
